This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

NIH NLM Logo
Log in
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 6;11(4):e0153219.
doi: 10.1371/journal.pone.0153219. eCollection 2016.

Deubiquitinase Ubp5 Is Required for the Growth and Pathogenicity of Cryptococcus gattii

Affiliations

Deubiquitinase Ubp5 Is Required for the Growth and Pathogenicity of Cryptococcus gattii

Yunfang Meng et al. PLoS One. .

Abstract

Cryptococcus gattii is a resurgent fungal pathogen that primarily infects immunocompetent hosts. Thus, it poses an increasingly significant impact on global public health; however, the mechanisms underlying its pathogenesis remain largely unknown. We conducted a detailed characterization of the deubiquitinase Ubp5 in the biology and virulence of C. gattii using the hypervirulent strain R265, and defined its properties as either distinctive or shared with C. neoformans. Deletion of the C. gattii Ubp5 protein by site-directed disruption resulted in a severe growth defect under both normal and stressful conditions (such as high temperature, high salt, cell wall damaging agents, and antifungal agents), similar to the effects observed in C. neoformans. However, unlike C. neoformans, the C. gattii ubp5Δ mutant displayed a slight enhancement of capsule and melanin production, indicating the evolutionary convergence and divergence of Ubp5 between these two sibling species. Attenuated virulence of the Cg-ubp5Δ mutant was not solely due to its reduced thermotolerance at 37°C, as shown in both worm and mouse survival assays. In addition, the assessment of fungal burden in mammalian organs further indicated that Ubp5 was required for C. gattii pulmonary survival and, consequently, extrapulmonary dissemination. Taken together, our work highlights the importance of deubiquitinase Ubp5 in the virulence composite of both pathogenic cryptococcal species, and it facilitates a better understanding of C. gattii virulence mechanisms.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Growth curve assay and colony size assessment.
A. The WT, mutant, and reconstituted strains were grown in YPD broth overnight at 30°C. Next, 106 cells of each strain were transferred to 30 mL fresh YPD broth in flasks and incubated at 30°C. The OD600 values were measured for each group at four-hour intervals. The growth rate of the Cg-ubp5Δ mutant was significantly reduced compared with the other two strains. B. One hundred cells from each strain were spread onto YPD agar, incubated for 5 days at 30°C and photographed.
Fig 2
Fig 2. C. gattii Ubp5 is involved in fungal responses to various stressors.
The R265, Cg-ubp5Δ, and Cg-ubp5Δ+UBP5 strains were grown on YPD broth to saturation at 30°C and then serially diluted 10-fold (1–106 dilutions). 3 μL suspension of 108 cells/mL were spotted on YPD or YNB agar (containing different stress-inducing agents), incubated for five days and photographed.
Fig 3
Fig 3. UBP5 mutation enhances capsule production in C. gattii.
A. The WT, mutant, and reconstituted strains were incubated on DMEM medium for capsule induction at 37°C for three days. Capsules were assessed by India ink staining and visualization at 100X magnification (scale bar = 10 μm). B. Relative capsule volume on DMEM medium. Relative capsule volume = (Total Volume–Packed Volume)/Total Volume (N = 50). Wilcoxon test was performed to examine the capsule difference between R265 and Cg-ubp5Δ strains. The results revealed enhanced capsule production in the Cg-ubp5Δ mutant strain (P<0.01).
Fig 4
Fig 4. Ubp5 negatively regulates melanin production in C. gattii.
Strains grown in YPD broth were washed twice with PBS buffer, and a 5 μL suspension of 107 cells/mL was spotted on L-DOPA and Caffeic Acid media and incubated for 5 days at 30°C for melanin induction.
Fig 5
Fig 5. Ubp5 mediates the survival and proliferation of C. gattii in macrophages.
Activated J774A.1 macrophages were infected with R265, Cg-ubp5Δ, and Cg-ubp5Δ+UBP5 strains of C. gattii. After 2 hours of coincubation at 37°C with 5% CO2, the extracellular yeasts were removed, and the co-cultures were incubated for 24 hours under the same conditions. The macrophages were lysed, and the samples were then incubated on YPD agar at 30°C for 4 days to quantify the cryptococcal colonies. Each strain was assayed four times (average ± SEM, P<0.0001).
Fig 6
Fig 6. Deletion of Ubp5 attenuates the virulence of C. gattii in a murine inhalation model.
A. Survival curve of mouse inhalational cryptococcosis with R265, Cg-ubp5Δ, and Cg-ubp5Δ+UBP5 strains over 80 days. All of the mice infected with R265 and Cg-ubp5Δ+UBP5 were sacrificed, but all of the mice in the Cg-ubp5Δ group survived (P<0.001). B&C. Fungal burden in the lung and brain. Organs were removed at 4, 7, 14, and 21 days post-infection in the three groups.
Fig 7
Fig 7. Survival analysis in the C. elegans model.
Forty C. elegans per group were fed on lawns of the WT, mutant, or reconstituted strain. Ubp5 deletion attenuated the virulence of C. gattii (P<0.001).

References

    1. Heitman J, Kozel TR, Kwon-Chung KJ, Perfect JR, Casadevall A. Cryptococcus: from human pathogen to model yeast Washington, DC: ASM Press; 2011.
    1. Chen S, Sorrell T, Nimmo G, Speed B, Currie B, Ellis D, et al. Epidemiology and host- and variety-dependent characteristics of infection due to Cryptococcus neoformans in Australia and New Zealand. Australasian Cryptococcal Study Group. Clin Infect Dis. 2000;31(2):499–508. Epub 2000年09月15日. 10.1086/313992 . - DOI - PubMed
    1. Sorrell TC. Cryptococcus neoformans variety gattii. Med Mycol. 2001;39(2):155–68. Epub 2001年05月11日. . - PubMed
    1. Kidd SE, Hagen F, Tscharke RL, Huynh M, Bartlett KH, Fyfe M, et al. A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A. 2004;101(49):17258–63. Epub 2004年12月02日. 10.1073/pnas.0402981101 ; PubMed Central PMCID: PMCPmc535360. - DOI - PMC - PubMed
    1. Springer DJ, Chaturvedi V. Projecting global occurrence of Cryptococcus gattii. Emerg Infect Dis. 2010;16(1):14–20. Epub 2009年12月25日. 10.3201/eid1601.090369 ; PubMed Central PMCID: PMCPmc2874352. - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

Cite

AltStyle によって変換されたページ (->オリジナル) /